It seems that there is some potential synergy in communication between NTI164 which was strong in verbal comm, and Daybue which was strong in communication choices, but weak in verbal! Maybe this is just randomness. In the second quote, caregivers seem not to mention anxiety and body rocking. So there may be some synergies between Daybue and NTI164.
Acadia/Neuren haven't released much on the make up of the CGI-S results. See link under the quote:
Daybue communication results: "
Results
Trofinetide demonstrated a statistically significant difference versus placebo for the CSBS-DP-IT Social Composite score (least squares mean [LSM] difference = 1.0; 95% confidence interval [CI], 0.3 to 1.7; P = 0.0064; Cohen's d effect size = 0.43) and a nominally significant difference for the RTT-COMC (LSM difference: −0.3; 95% CI, −0.6 to −0.0; P = 0.0257; Cohen's d effect size = 0.36). As expected, there was no difference for the RTT-VCOM."
https://www.sciencedirect.com/science/article/pii/S0887899423004058
"27 caregivers of 26 study participants took part in optional exit interviews to explore the patients’ experiences with Rett syndrome and DAYBUE during the trials. The most frequently reported improvements observed by caregivers to participants treated with DAYBUE in the studies were engagement with others (46.2%), hand use (42.3%), and eye gaze (30.8%). Caregivers also reported that some participants acquired new sounds (23.1%) or words (19.2%)."
https://acadia.com/media/news-relea...ide-in-patients-with-rett-syndrome-published/
- Forums
- ASX - By Stock
- Ann: Rett Syndrome Phase I/II trial shows significant benefits
It seems that there is some potential synergy in communication...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $55.86M |
Open | High | Low | Value | Volume |
5.4¢ | 5.5¢ | 5.3¢ | $33.62K | 629.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 3755572 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 120107 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 3755572 | 0.053 |
1 | 10000 | 0.052 |
5 | 490000 | 0.051 |
7 | 1576610 | 0.050 |
1 | 50000 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 120107 | 3 |
0.056 | 272183 | 2 |
0.058 | 138813 | 3 |
0.060 | 376997 | 3 |
0.061 | 488500 | 2 |
Last trade - 14.27pm 08/11/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online